Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.041 USD | +5.13% | +24.62% | +15.82% |
Mar. 28 | Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 26 | CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews | CI |
Financials (USD)
Sales 2021 | 20.05M | Sales 2022 | 16.2M | Capitalization | 4.95M |
---|---|---|---|---|---|
Net income 2021 | -15M | Net income 2022 | -9M | EV / Sales 2021 | 0.63 x |
Net cash position 2021 | 453K | Net Debt 2022 | 917K | EV / Sales 2022 | 0.36 x |
P/E ratio 2021 |
-0.81
x | P/E ratio 2022 |
-0.44
x | Employees | 43 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
Latest transcript on CV Sciences, Inc.
1 day | +5.13% | ||
1 week | +24.62% | ||
Current month | +19.53% | ||
1 month | +20.59% | ||
3 months | +20.59% | ||
6 months | -19.61% | ||
Current year | +15.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 14-06-15 | |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 18-12-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 14-06-15 | |
Jamie Corroon
BRD | Director/Board Member | 54 | 22-07-20 |
William McCorkle
BRD | Director/Board Member | 56 | 22-10-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.041 | +5.13% | 1,459,834 |
24-03-27 | 0.039 | 0.00% | 174,207 |
24-03-26 | 0.039 | 0.00% | 230,380 |
24-03-25 | 0.039 | +8.33% | 193,563 |
24-03-22 | 0.036 | +9.36% | 644,858 |
Delayed Quote OTC Markets, March 28, 2024 at 03:58 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+15.82% | 6.71M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+2.95% | 212B | |
+0.74% | 209B | |
-6.05% | 205B | |
-3.61% | 157B |